#1176 Patients who smoke during concurrent chemoradiation for limited small cell lung cancer have decreased survival (excerpts) GMM Videtic, L Stitt Dana-Farber Cancer Center Inst., Boston, MA; London Regional Cancer Centre, London, On, Canada Results: Median overall survival non-smoker (18 months), smoker (13.6 months). 2-year survival non-smoker (28 %), smoker (13.6 %) and 5-year survival non-smoker (8.9 %), smoker (4 %). Conclusion: Patients who continue to smoke during therapy have poorer survival rates than those who do not but this is not attributable to smokers having poorer tolerance for treatment. Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.